Acetohydroxamic acid

CAS No. 546-88-3

Acetohydroxamic acid( AHA | NSC 5073 | NSC 176136 | NSC 408425 )

Catalog No. M14966 CAS No. 546-88-3

Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 27 In Stock
200MG Get Quote In Stock
500MG 50 In Stock
1G 73 In Stock

Biological Information

  • Product Name
    Acetohydroxamic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea.
  • Description
    Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly. It is used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AHA | NSC 5073 | NSC 176136 | NSC 408425
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    546-88-3
  • Formula Weight
    75.07
  • Molecular Formula
    C2H5NO2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    CC(NO)=O
  • Chemical Name
    Acetamide, N-hydroxy- (9CI)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Palinska KA, et al. Microbiology. 2000 Dec;146 Pt 12:3099-107.
molnova catalog
related products
  • NNGH

    NNGH is a matrix metalloproteinase 3 (MMP-3) inhibitor with anticancer activity that counteracts the inhibitory effects of E2 and DHT on RANKL membrane binding.

  • Dehydroeffusol

    Dehydroeffusol possesses anti-cancer, anxiolytic and sedative properties. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis.

  • Bacoside A

    Bacoside A has a possible anticancer activity that could be inducing cell cycle arrest and apoptosis through Notch pathway in GBM in vitro.